| Title: |
High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translation |
| Authors: |
Luteijn, Maartje J.; Bhaskar, Varun; Trojer, Dominic; Schürz, Melanie; Mahboubi, Hicham; Handl, Cornelia; Pizzato, Nicolas; Pfeifer, Martin; Dafinca, Ruxandra; Voshol, Hans; Giorgetti, Elisa; Manneville, Carole; Garnier, Isabelle P.M.; Müller, Matthias; Zeng, Fanning; Buntin, Kathrin; Markwalder, Roger; Schröder, Harald; Weiler, Jan; Khar, Dora; Vahsen, Björn F.; Ripin, Nina; Clery, Antoine; Allain, Frederic |
| Source: |
Nucleic Acids Research, 53 (7) |
| Publisher Information: |
Oxford University Press |
| Publication Year: |
2025 |
| Collection: |
ETH Zürich Research Collection |
| Description: |
An intronic G4C2 repeat expansion in the C9ORF72 gene is the major known cause for Amyotrophic Lateral Sclerosis (ALS), with current evidence for both, loss of function and pathological gain of function disease mechanisms. We screened 96 200 small molecules in C9ORF72 patient iPS neurons for modulation of nuclear G4C2 RNA foci and identified 82 validated hits, including the Brd4 inhibitor JQ1 as well as novel analogs of Spliceostatin-A, a known modulator of SF3B1, the branch point binding protein of the U2-snRNP. Spliceosome modulation by these SF3B1 targeted compounds recruits SRSF1 to nuclear G4C2 RNA, mobilizing it from RNA foci into nucleocytoplasmic export. This leads to increased repeat-associated non-canonical (RAN) translation and ultimately, enhanced cell toxicity. Our data (i) provide a new pharmacological entry point with novel as well as known, publicly available tool compounds for dissection of C9ORF72 pathobiology in C9ORF72 ALS models, (ii) allowing to differentially modulate RNA foci versus RAN translation, and (iii) suggest that therapeutic RNA foci elimination strategies warrant caution due to a potential storage function, counteracting translation into toxic dipeptide repeat polyproteins. Instead, our data support modulation of nuclear export via SRSF1 or SR protein kinases as possible targets for future pharmacological drug discovery. ; ISSN:1362-4962, 0301-5610 ; ISSN:0301-5610 |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/application/pdf |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/wos/001464200500010; https://hdl.handle.net/20.500.11850/731979 |
| DOI: |
10.3929/ethz-b-000731979 |
| Availability: |
https://hdl.handle.net/20.500.11850/731979; https://doi.org/10.3929/ethz-b-000731979 |
| Rights: |
info:eu-repo/semantics/openAccess ; http://creativecommons.org/licenses/by-nc/4.0/ ; Creative Commons Attribution-NonCommercial 4.0 International |
| Accession Number: |
edsbas.407EEF91 |
| Database: |
BASE |